Alessandro Russo(@Al3ssandroRusso) 's Twitter Profileg
Alessandro Russo

@Al3ssandroRusso

Medical Oncologist at A.O. Papardo, Messina (Italy)

ID:1112054632396800003

calendar_today30-03-2019 18:11:00

1,3K Tweets

835 Followers

531 Following

International Society of Liquid Biopsy(@isliquidbiopsy) 's Twitter Profile Photo

The ISLB president presenting an overview of the role of extracellular vesicles (EV) and circulating tumor cells in diagnosis/response monitoring in patients with NSCLC at NIH Liquid Biopsy Conference in Bethesda, MD
The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai

The ISLB president presenting an overview of the role of extracellular vesicles (EV) and circulating tumor cells in diagnosis/response monitoring in patients with NSCLC at @NIH Liquid Biopsy Conference in Bethesda, MD @TischCancer @IcahnMountSinai
account_circle
JCO Precision Oncology(@JCOPO_ASCO) 's Twitter Profile Photo

🎧 In this JCO Precision Oncology Conversations podcast ep, host Rafeh Naqash, MD speaks w/ Christian Rolfo
about his publication, “Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment.” ➡️ brnw.ch/21wJLyN

🎧 In this JCO Precision Oncology Conversations podcast ep, host @thenasheffect speaks w/ @ChristianRolfo about his #JCOPO publication, “Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment.” ➡️ brnw.ch/21wJLyN
account_circle
I-Mei (Emay) Siu(@imsmd) 's Twitter Profile Photo

Great overview of the role of extracellular vesicles (EV) and circulating tumor cells in diagnosis/response monitoring in patients with NSCLC by Christian Rolfo, who also highlighted future directions for the EV field

Great overview of the role of extracellular vesicles (EV) and circulating tumor cells in diagnosis/response monitoring in patients with NSCLC by @ChristianRolfo, who also highlighted future directions for the EV field
account_circle
Biagio Ricciuti, MD PhD(@BiagioRicciutMD) 's Twitter Profile Photo

Comprehensive mutational scanning of reveals TKI sensitivities of extracellular domain mutants. shorturl.at/lrI45

🧬Multiple EGFR extracellular domain variants, not associated with approved targeted therapies, were sensitive to afatinib and dacomitinib in vitro.

account_circle
BLOODPAC(@blood_pac) 's Twitter Profile Photo

BLOODPAC welcomes our newest member, ISLB! International Society of Liquid Biopsy is building a global network dedicated to the study of Liquid Biopsy, creating awareness and erasing limits in the technology access between countries or specialties. We welcome their expertise!

BLOODPAC welcomes our newest member, ISLB! @isliquidbiopsy is building a global network dedicated to the study of Liquid Biopsy, creating awareness and erasing limits in the technology access between countries or specialties. We welcome their expertise!
account_circle
Christian Rolfo(@ChristianRolfo) 's Twitter Profile Photo

Happy to share our collaboration with ⁦VCDenninghoff⁩ in ⁦IASLC⁩ ILNC discussing Increased Biomarker Uptake Needed to Further Realize Potential of Precision Medicine ⁦International Society of Liquid BiopsyOncoAlert⁩ ilcn.org/increased-biom…

account_circle
Diego de Miguel Perez(@ddemiguelperez) 's Twitter Profile Photo

Happy to share our lastest review on the potential uses of engineered extracellular vesicles in cancer therapeutics! The result of combined efforts with Marina Perez-Capo and Antonia Obrador-Hevia from IdISBa and Christian Rolfo Icahn School of Medicine at Mount Sinai

authors.elsevier.com/c/1j19v_u8hB-0…

account_circle
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

Dr. Christian Rolfo discusses the potential role of ctDNA in guiding use of immunotherapy for NSCLC at . Monitoring ctDNA dynamics with liquid biopsy may provide escalation strategies and need to be properly integrated into prospective clinical trials.

Dr. @ChristianRolfo discusses the potential role of ctDNA in guiding use of immunotherapy for NSCLC at #RomeLung24. Monitoring ctDNA dynamics with liquid biopsy may provide escalation strategies and need to be properly integrated into prospective clinical trials.
account_circle
Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo

🔥Pembrolizumab + chemo for metastatic NSCLC with PD-L1 TPS < 1%
🎙️Dr. Shirish M. Gadgeel JTO & JTO CRR IASLC
🎯KEYNOTE series trials after 5 years of F/U
✅Pooled Analysis
✅Primary: OS
✅NCT02578680, NCT03950674, NCT02775435, NCT03875092
OncoAlert
jto.org/article/S1556-…

account_circle
Christian Rolfo(@ChristianRolfo) 's Twitter Profile Photo

🚨Thanks ⁦⁦Dr Rafeq Naqash Rafeh Naqash, MD⁩ for the kind invitation to ⁦JCO Precision Oncology⁩ conversations podcast 🎤on our paper📝“Liquid Biopsy of Lung Cancer Before Path Diagnosis”⁦⁩ ⁦Alessandro Russo⁩ ⁦Lincoln Pasquina⁩ ⁦ASCO⁩ sites.libsyn.com/427415/liquid-…

account_circle
Andres F. Cardona(@AndresFCardonaZ) 's Twitter Profile Photo

Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation aacrjournals.org/clincancerres/…

account_circle